Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Redox-sensitive cellular components are a broad class of biological molecules, including proteins, lipids, and nucleic acids, that undergo structural or functional changes in response to variations in the cellular reduction-oxidation (redox) environment (NIH, 2020; PubMed, 2022). These components often feature reactive chemical groups, such as cysteine thiol residues, which serve as sensors for reactive oxygen species (ROS) or intracellular reductants like glutathione (GSH) (PubMed, 2014; NIH, 2021). Under physiological conditions, these components are critical for maintaining redox homeostasis and mediating signaling pathways, such as the Nrf2-Keap1 antioxidant response system (Spandidos Publications, 2020). In pathological states like cancer, neurodegeneration, and cardiovascular disease, the dysregulation of these components leads to oxidative stress or the activation of cell death pathways like ferroptosis (ACS Central Science, 2016; NIH, 2022). Therapeutic strategies targeting these components include the use of antioxidants to prevent oxidative damage or pro-oxidant drugs designed to overwhelm the redox defenses of diseased cells (Frontiers in Pharmacology, 2021). Furthermore, the distinct redox gradients found in tumor microenvironments are increasingly utilized to trigger the release of drugs from redox-sensitive prodrugs and nanocarriers (ACS, 2025).
Modulation of cellular redox state, induction of antioxidant response, inhibition of lipid peroxidation, or covalent modification of redox-sensitive cysteine residues.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Redox-sensitive cellular components.